Albert Labs International (XCNQ:ABRT) EBIT per Share : C$0.02 (TTM As of Sep. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International EBIT per Share?

Albert Labs International's EBIT per Share for the three months ended in Sep. 2023 was C$0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 was C$0.02.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Albert Labs International's EBIT per Share or its related term are showing as below:

XCNQ:ABRT's 3-Year EBIT Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 3.45
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Albert Labs International's EBIT for the three months ended in Sep. 2023 was C$-0.02 Mil.

Albert Labs International EBIT per Share Historical Data

The historical data trend for Albert Labs International's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International EBIT per Share Chart

Albert Labs International Annual Data

Trend

Dec21

Dec22

EBIT per Share

-0.03

-0.07

Albert Labs International Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
EBIT per Share	Get a 7-Day Free Trial					-0.01	0.03	-0.01	-	-

Albert Labs International EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Albert Labs International's EBIT per Share for the fiscal year that ended in Dec. 2022 is calculated as

	EBIT per Share		(A: Dec. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-4.141	/	56.415
=	-0.07

Albert Labs International's EBIT per Share for the quarter that ended in Sep. 2023 is calculated as

	EBIT per Share		(Q: Sep. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.017	/	74.413
=	-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.02

Albert Labs International (XCNQ:ABRT) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Albert Labs International EBIT per Share Related Terms

Thank you for viewing the detailed overview of Albert Labs International's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Albert Labs International (XCNQ:ABRT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6

Website

https://www.albertlabs.com

Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International (XCNQ:ABRT) Headlines

No Headlines